1. 2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3 – LBA, biomarkers and immunogenicity). (December 2015) Authors: Amaravadi, Lakshmi; Song, An; Myler, Heather; Thway, Theingi; Kirshner, Susan; Devanarayan, Viswanath; Ni, Yan G; Garofolo, Fabio; Birnboeck, Herbert; Richards, Susan; Gupta, Shalini; Luo, Linlin; Kingsley, Clare; Salazar-Fontana, Laura; Fraser, Stephanie; Gorovits, Boris; Allinson, John; Barger,... Journal: Bioanalysis Issue: Volume 7:Number 24(2015) Page Start: 3107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE. Issue 1 (30th March 2015) Authors: Kennedy, William P; Maciuca, Romeo; Wolslegel, Kristen; Tew, Wei; Abbas, Alexander R; Chaivorapol, Christina; Morimoto, Alyssa; McBride, Jacqueline M; Brunetta, Paul; Richardson, Bruce C; Davis, John C; Behrens, Timothy W; Townsend, Michael J Journal: Lupus science & medicine Issue: Volume 2:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Commercial biomarker assays: friend and foe. (November 2016) Authors: Fischer, Saloumeh K; Carrasco-Triguero, Montserrat; Hong, Kyu; Good, Jeremy; Davancaze, Teresa; Nguy, Trung; Li, Jessica; Darbonne, Walter; Morimoto, Alyssa; Zhu, Yuda Journal: Bioanalysis Issue: Volume 8:Number 22(2016) Page Start: 2351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fit-for-purpose biomarker immunoassay qualification and validation: three case studies. (November 2016) Authors: Cowan, Kyra; Gao, Xiaoying; Parab, Vaishali; Nguy, Trung; Wu, Lawren; Arron, Joseph R; Townsend, Michael; Wallin, Jeffrey; Cheu, Melissa; Morimoto, Alyssa; Wakshull, Eric Journal: Bioanalysis Issue: Volume 8:Number 22(2016) Page Start: 2329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0129 THE BTK INHIBITOR, FENEBRUTINIB, EFFECTIVELY MODULATES B AND MYELOID CELL BIOLOGY IN RHEUMATOID ARTHRITIS PATIENTS. (June 2019) Authors: Morimoto, Alyssa; Rae, Julie; Chinn, Leslie; Ramamoorthi, Nandhini; Hwang, Olivia; Ward, Alexandra; James Haddon, D.; Looney, Caroline; Desai, Rupal; Toth, Balazs; Tuckwell, Katie; Townsend, Michael J. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients. Issue 2 (19th January 2023) Authors: Looney, Cary M.; Schroeder, Aaron; Tavares, Erica; Garg, Jay; Schindler, Thomas; Vincenti, Flavio; Redfield, Robert R.; Jordan, Stanley C.; Busque, Stephan; Woodle, E. Steve; Khan, Jared; Eastham, Jeffrey; Micallef, Sandrine; Austin, Cary D.; Morimoto, Alyssa Journal: Transplantation direct Issue: Volume 9:Issue 2(2023) Page Start: e1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development. (January 2015) Authors: Khan, Masood U; Bowsher, Ronald R; Cameron, Mark; Devanarayan, Viswanath; Keller, Steve; King, Lindsay; Lee, Jean; Morimoto, Alyssa; Rhyne, Paul; Stephen, Laurie; Wu, Yuling; Wyant, Timothy; Lachno, D Richard Journal: Bioanalysis Issue: Volume 7:Number 2(2015) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development. (January 2015) Authors: Khan, Masood U; Bowsher, Ronald R; Cameron, Mark; Devanarayan, Viswanath; Keller, Steve; King, Lindsay; Lee, Jean; Morimoto, Alyssa; Rhyne, Paul; Stephen, Laurie; Wu, Yuling; Wyant, Timothy; Lachno, D Richard Journal: Bioanalysis Issue: Volume 7:Number 2(2015) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Issue 10038 (25th June 2016) Authors: Khanna, Dinesh; Denton, Christopher P; Jahreis, Angelika; van Laar, Jacob M; Frech, Tracy M; Anderson, Marina E; Baron, Murray; Chung, Lorinda; Fierlbeck, Gerhard; Lakshminarayanan, Santhanam; Allanore, Yannick; Pope, Janet E; Riemekasten, Gabriela; Steen, Virginia; Müller-Ladner, Ulf; Lafyatis, ... Journal: Lancet Issue: Volume 387:Issue 10038(2016) Page Start: 2630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti‐CD20 monoclonal antibody for the desensitization of candidates for renal transplant. Issue 11 (23rd July 2019) Authors: Redfield, Robert R.; Jordan, Stanley C.; Busque, Stephan; Vincenti, Flavio; Woodle, E. Steve; Desai, Niraj; Reed, Elaine F.; Tremblay, Simon; Zachary, Andrea A.; Vo, Ashley A.; Formica, Richard; Schindler, Thomas; Tran, Ha; Looney, Caroline; Jamois, Candice; Green, Cherie; Morimoto, Alyssa; Rajwa... Journal: American journal of transplantation Issue: Volume 19:Issue 11(2019) Page Start: 3035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗